NCT00222105View on ClinicalTrials.gov

A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

April 30, 2009

Study Completion Date

July 31, 2009

Conditions
Multiple Myeloma
Interventions
DRUG

Doxil

Doxil 40 mg/m2 IV day 1

DRUG

Thalidomide

50-100 mg day 1-28

DRUG

Dexamethasone

Dexamethasone 40 mg day 1-4 and 15-18

Sponsors

Collaborators (1)

Ortho Biotech, Inc.
All Listed Sponsors
collaborator

Ortho Biotech, Inc.

INDUSTRY

lead

University of Kansas Medical Center

OTHER